All Drugs Associated with Deafness neurosensory
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
219 drugs have been associated with Deafness neurosensory in FAERS reports.
| Drug | Reports | Deaths | Hosp. | Life-Threat. |
|---|---|---|---|---|
| METHOTREXATE | 224 | 4 | 172 | 0 |
| FENTANYL | 202 | 0 | 168 | 5 |
| OXYCODONE | 198 | 0 | 176 | 4 |
| ETANERCEPT | 171 | 0 | 153 | 0 |
| TEPROTUMUMAB-TRBW | 171 | 1 | 18 | 0 |
| TOCILIZUMAB | 164 | 1 | 157 | 0 |
| HYDROXYCHLOROQUINE | 162 | 0 | 144 | 0 |
| SULFASALAZINE | 153 | 0 | 150 | 0 |
| ABATACEPT | 149 | 0 | 148 | 0 |
| CELECOXIB | 143 | 0 | 143 | 0 |
| GABAPENTIN | 143 | 0 | 140 | 0 |
| GOLD THIOMALATE | 138 | 0 | 138 | 0 |
| CISPLATIN | 119 | 6 | 12 | 3 |
| PREDNISONE | 97 | 1 | 27 | 0 |
| LEFLUNOMIDE | 89 | 0 | 82 | 0 |
| AMIKACIN | 72 | 2 | 27 | 0 |
| CARBOPLATIN | 69 | 5 | 7 | 3 |
| ALPRAZOLAM | 62 | 0 | 30 | 8 |
| CYCLOPHOSPHAMIDE | 62 | 10 | 5 | 0 |
| ADALIMUMAB | 60 | 0 | 16 | 0 |
| VINCRISTINE | 57 | 1 | 6 | 3 |
| PREDNISOLONE | 55 | 1 | 5 | 1 |
| RITUXIMAB | 53 | 1 | 26 | 0 |
| GENTAMICIN | 48 | 1 | 9 | 3 |
| ETOPOSIDE | 47 | 5 | 5 | 3 |
| LINEZOLID | 44 | 3 | 22 | 0 |
| NORTRIPTYLINE | 41 | 0 | 38 | 0 |
| FLUOROURACIL | 39 | 0 | 5 | 3 |
| AZITHROMYCIN ANHYDROUS | 37 | 0 | 18 | 0 |
| DEXAMETHASONE | 37 | 0 | 12 | 0 |
| AZITHROMYCIN | 36 | 0 | 6 | 0 |
| DOXORUBICIN | 36 | 4 | 5 | 3 |
| CLOFAZIMINE | 34 | 3 | 18 | 0 |
| BUPRENORPHINE | 33 | 0 | 16 | 5 |
| METRONIDAZOLE | 33 | 0 | 8 | 1 |
| NIVOLUMAB | 33 | 0 | 13 | 1 |
| SERTRALINE | 33 | 0 | 0 | 0 |
| SILDENAFIL | 31 | 2 | 4 | 0 |
| TOFACITINIB | 29 | 0 | 27 | 0 |
| CLARITHROMYCIN | 27 | 0 | 8 | 0 |
| FUROSEMIDE | 27 | 0 | 7 | 0 |
| VANCOMYCIN | 27 | 0 | 6 | 1 |
| ACETAMINOPHEN | 26 | 0 | 8 | 1 |
| MOXIFLOXACIN | 26 | 0 | 14 | 0 |
| ETHAMBUTOL | 25 | 1 | 13 | 0 |
| HYDROXYCHLOROQUINE DIPHOSPHATE | 25 | 0 | 25 | 0 |
| TOBRAMYCIN | 24 | 0 | 13 | 0 |
| INFLIXIMAB | 23 | 0 | 4 | 0 |
| TADALAFIL | 23 | 1 | 3 | 0 |
| IBUPROFEN | 22 | 0 | 18 | 0 |